Please select the option that best describes you:

Do you time initiation of definitive radiation on PSA response to neoadjuvant ADT?  

Is there any benefit to delaying start of RT or perhaps changing to complete adrogen blockage if maximal PSA response is not achieved in 2 mo?  

What PSA metric are you using, for example, <0.3, <0.1, other?  

Do you feel PSA reponse to ADT is a surrogate for less agressive disease or does allowing a more robust PSA repsone actually result in "more" radiosensitization and potentially better outcome?



Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more

Answer from: Radiation Oncologist at Community Practice
Sign in or Register to read more